235 related articles for article (PubMed ID: 17514187)
1. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
Sheehan DV; Sheehan KH; Raj BA
Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
[TBL] [Abstract][Full Text] [Related]
2. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
[No Abstract] [Full Text] [Related]
3. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.
Pecknold J; Luthe L; Munjack D; Alexander P
J Clin Psychopharmacol; 1994 Oct; 14(5):314-21. PubMed ID: 7806686
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers.
Glue P; Fang A; Gandelman K; Klee B
Am J Ther; 2006; 13(5):418-22. PubMed ID: 16988537
[TBL] [Abstract][Full Text] [Related]
5. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
[TBL] [Abstract][Full Text] [Related]
6. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
Pols H; Verburg K; Hauzer R; Meijer J; Griez E
Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
[TBL] [Abstract][Full Text] [Related]
7. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
[TBL] [Abstract][Full Text] [Related]
8. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
Klein E
J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
[TBL] [Abstract][Full Text] [Related]
9. [Clinical use of sustained release of alprazolam: A naturalistic study].
De La Gándara Martín JJ; Sanz Granado O; Varona Martínez A; Such P
Actas Esp Psiquiatr; 1999; 27(3):191-7. PubMed ID: 10431062
[TBL] [Abstract][Full Text] [Related]
10. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
Ravaris CL; Friedman MJ; Hauri PJ; McHugo GJ
J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
[TBL] [Abstract][Full Text] [Related]
11. Xanax XR for panic disorder.
Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
[No Abstract] [Full Text] [Related]
12. Personality dimensions in panic disorder before and after effective treatment.
Starcevic V; Uhlenhuth EH
Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
[No Abstract] [Full Text] [Related]
13. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders.
Márquez M; Arenoso H; Caruso N
Actas Esp Psiquiatr; 2011; 39(2):88-94. PubMed ID: 21404147
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
Schweizer E; Patterson W; Rickels K; Rosenthal M
Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
[TBL] [Abstract][Full Text] [Related]
16. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
[TBL] [Abstract][Full Text] [Related]
17. Alprazolam extended-release in panic disorder.
Rickels K
Expert Opin Pharmacother; 2004 Jul; 5(7):1599-611. PubMed ID: 15212610
[TBL] [Abstract][Full Text] [Related]
18. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
19. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
Greenblatt DJ; Harmatz JS; Shader RI
Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
[TBL] [Abstract][Full Text] [Related]
20. Alpidem in the treatment of panic disorder.
Schneier FR; Carrasco JL; Hollander E; Campeas R; Fallon B; Saoud JB; Feerick J; Liebowitz MR
J Clin Psychopharmacol; 1993 Apr; 13(2):150-3. PubMed ID: 8096527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
